Zimmer Biomet Holdings, Inc. (ZBH) Institutional Ownership & Insider Trading

905 institutions reported holding Zimmer Biomet Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 6 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZBHZimmer Biomet Holdings, Inc.Follow ZBH — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 18.8B
P/E TTM: 23.9
Dividend yield: 1.0%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

905 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +2.6%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	905	198	+2.6%	278	64	272	66
Mar 26	905	192	-2.5%	280	58	265	82
Dec 25	927	198	+2.0%	233	56	343	99
Sep 25	942	192	+0.8%	273	72	282	43
Jun 25	919	192	+4.2%	260	65	316	113
Mar 25	979	182	+1.3%	244	50	335	78
Dec 24	995	182	-1.6%	251	71	320	65
Sep 24	954	179	-4.1%	246	52	352	73

Zimmer Biomet Holdings, Inc. — questions

Who owns Zimmer Biomet Holdings, Inc. stock?: 905 institutions reported Zimmer Biomet Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Dodge & Cox (12.7%), BlackRock, Inc. (8.2%), HARRIS ASSOCIATES L P (6.7%).
Are Zimmer Biomet Holdings, Inc. insiders buying or selling?: 6 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Zimmer Biomet Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.